Imidazo[1,2-a]pyridine-7-carbaldehyde

Catalog No. :
ACVGNH391
CAS No. :
136117-73-2
Molecular Formula :
C8H6N2O
Molecular Weight :
146.15

IUPAC Name:imidazo[1,2-a]pyridine-7-carbaldehyde

Imidazo[1,2-a]pyridine-7-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$195.00Login to see priceIn stockInquiry
25g97%$972.00Login to see priceIn stockInquiry
100g97%$3635.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameImidazo[1,2-a]pyridine-7-carbaldehyde
IUPAC Nameimidazo[1,2-a]pyridine-7-carbaldehyde
MDL No.MFCD09910326
Molecular FormulaC8H6N2O
Molecular Weight146.15
SMILESO=CC1=CC2=NC=CN2C=C1
InChI KeyQUMWTXLNMLEBJH-UHFFFAOYSA-N
SynonymIMIDAZO[1,2-A]PYRIDINE-7-CARBALDEHYDE | 136117-73-2 | IMIDAZO[1,2-A]PYRIDINE-7-CARBOXALDEHYDE | Imidazo[1,2-a]pyridine-7-carboxaldehyde (9CI) | MFCD09910326 | SCHEMBL557320 | AMY3700 | DTXSID10452450 | QUMWTXLNMLEBJH-UHFFFAOYSA-N | AKOS022717798 | PB17705 | AS-33733 | SY097524 | C
CAS No.136117-73-2
PubChem CID11029972

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338-P405-P501

Synthetic Route by SureRoute

1. ACVGNH391 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWDBM832 route compound structure diagram
    ACWDBM832342613-80-3 In Stock
  2. Then
  3. ACVGNH391 route product structure diagram
    ACVGNH391136117-73-2 In Stock
Inquiry

2. ACVGNH391 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWDBM832 route compound structure diagram
    ACWDBM832342613-80-3 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACVGNH391 route product structure diagram
    ACVGNH391136117-73-2 In Stock
Inquiry

Comments (0)